Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.32472
+0.00082 (0.25%)
At close: Nov 20, 2026
Elite Pharmaceuticals Revenue
Elite Pharmaceuticals had revenue of $40.08M in the quarter ending September 30, 2026, with 10.35% growth. This brings the company's total for the last twelve months to $144.77M, up 17.81% year-over-year. In the fiscal year ending March 31, 2026, Elite Pharmaceuticals had annual revenue of $148.87M with 77.13% growth. That makes Elite Pharmaceuticals the 19,925th largest company in the world by revenue and 3,066th in the United States.
Revenue (ttm)
144.77M
Revenue Growth
+17.81%
P/S Ratio
2.42
Revenue / Employee
2.23M
Employees
65
Market Cap
349.88M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 148.87M | 64.83M | 77.13% |
| Mar 31, 2025 | 84.04M | 27.42M | 48.42% |
| Mar 31, 2024 | 56.63M | 22.47M | 65.79% |
| Mar 31, 2023 | 34.16M | 1.89M | 5.87% |
| Mar 31, 2022 | 32.26M | 6.88M | 27.11% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 373.80M |
| Eagle Pharmaceuticals | 257.55M |
| MariMed | 167.28M |
| Earth Science Tech | 34.21M |
| Radnostix | 10.52M |
| Healthy Extracts | 5.99M |
| Bio Essence | 3.03M |
Elite Pharmaceuticals News
- 8 days ago - Elite Pharmaceuticals Earnings Call Transcript: Q2 2027 - Transcripts
- 8 days ago - Elite Pharmaceuticals Quarterly report: Q2 2027 - Filings
- 8 days ago - Elite Pharmaceuticals Earnings release: Q2 2027 - Filings
- 9 days ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2027 ended September 30, 2026 and Provides Conference Call Information - Newsfile Corp
- 11 days ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter of Fiscal Year 2027 Financial Results on November 13, 2026 - Newsfile Corp
- 18 days ago - Elite Pharmaceuticals Expands Board of Directors with Election of Aqeel A. Fatmi, Ph.D. - Newsfile Corp
- 3 months ago - Elite Pharmaceuticals Earnings Call Transcript: Q1 2027 - Transcripts
- 3 months ago - Elite Pharmaceuticals Quarterly report: Q1 2027 - Filings